Astellas Pharma Company Profile

Aggregated data from the web about Astellas Pharma

Company Name	Astellas Pharma
Website	https://www.astellas.com
Snippet	Nov 20, 2019 · Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. ... Astellas was established in 2005 through merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical CO., Ltd. and has a rich history ...
Type	Public (K.K)
Founded	2005
Revenue	US$11,060,000,000 (FY 2013)
Website	www.astellas.com/en/
Industry	Pharmaceutical
Products	Prograf, Harnal, Vesicare, Funguard/Mycamine, Protopic, and other pharmaceuticals
Traded as	TYO: 4503, TOPIX Core 30 Component, TOPIX 100 Component, Nikkei 225 Component
Key people	Kenji Yasukawa(President and CEO)
Net income	US$1,280,000,000 (¥1,139,000,000,000) (FY 2013)
Headquarters	2-5-1, Nihonbashi-Honcho, Chūō-ku, Tokyo 103-8411, Japan
Predecessors	Yamanouchi PharmaceuticalFujisawa Pharmaceutical(Merged in 2005)
Subsidiaries	Astellas US
Total assets	$14.86 billion (2016)[1]
Number of employees	17,217 (2016)[2]

Astellas Pharma is part of the Japan company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.